€ 26.64
Key Takeaways
Risk factor
Good trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Target Price
The average target price of GXI.DE is 43 and suggests 60% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
